SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Raul Prytog who wrote (929)5/19/1999 9:20:00 PM
From: Investor Dave  Read Replies (1) of 998
 
Hi all,

It appears that Provigil is going to be the revenue producing drug for Cephalon. The approval of Mytrophin may help the bottom line some. But, I don't think its approval will have much effect on Cephelon's stock price. It appears to me that the FDA has been reviewing Myotrophin's results for what seems a lifetime.

Any input on this?

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News